Just 3 people are responsible for 30% of infants and mothers in the US receiving unnecessary antibiotics during birth, and they are refusing to address concerns about the validity of their recommendations. (Dec 2019, GBS, Group-B Strep)

[Michael Harrop]

Pubpeer: Management of Infants at Risk for Group B Streptococcal Disease Pediatrics (2019) https://pubpeer.com/publications/3EF4D14A136E195025193576F6D8C2

Related:
Challenging the validity of the new and old USA GBS guidelines. (Oct 2019)

An analytical, cost-benefit approach to antibiotics that questions the ethics and intelligence of each decision (Oct 2022)


15 Dec 2019 discussion.